• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习的金黄色葡萄球菌菌血症患者感染性心内膜炎预测风险评分——SABIER 评分。

A Machine Learning-Based Risk Score for Prediction of Infective Endocarditis Among Patients With Staphylococcus aureus Bacteremia-The SABIER Score.

机构信息

Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

S.H. Ho Research Centre for Infectious Diseases, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

出版信息

J Infect Dis. 2024 Sep 23;230(3):606-613. doi: 10.1093/infdis/jiae080.

DOI:10.1093/infdis/jiae080
PMID:38420871
Abstract

BACKGROUND

Early risk assessment is needed to stratify Staphylococcus aureus infective endocarditis (SA-IE) risk among patients with S. aureus bacteremia (SAB) to guide clinical management. The objective of the current study was to develop a novel risk score that is independent of subjective clinical judgment and can be used early, at the time of blood culture positivity.

METHODS

We conducted a retrospective big data analysis from territory-wide electronic data and included hospitalized patients with SAB between 2009 and 2019. We applied a random forest risk scoring model to select variables from an array of parameters, according to the statistical importance in predicting SA-IE outcome. The data were divided into derivation and validation cohorts. The areas under the curve of the receiver operating characteristic (AUCROCs) were determined.

RESULTS

We identified 15 741 SAB patients, among them 658 (4.18%) had SA-IE. The AUCROC was 0.74 (95%CI 0.70-0.76), with a negative predictive value of 0.980 (95%CI 0.977-0.983). The four most discriminatory features were age, history of infective endocarditis, valvular heart disease, and community onset.

CONCLUSIONS

We developed a novel risk score with performance comparable with existing scores, which can be used at the time of SAB and prior to subjective clinical judgment.

摘要

背景

需要早期风险评估来对金黄色葡萄球菌菌血症(SAB)患者的金黄色葡萄球菌感染性心内膜炎(SA-IE)风险进行分层,以指导临床管理。本研究的目的是开发一种新的风险评分,该评分不依赖于主观临床判断,并且可以在血培养阳性时早期使用。

方法

我们对全港范围内的电子数据进行了回顾性大数据分析,纳入了 2009 年至 2019 年住院的 SAB 患者。我们根据预测 SA-IE 结果的统计学重要性,应用随机森林风险评分模型从一系列参数中选择变量。将数据分为推导和验证队列。确定接收者操作特征曲线下的面积(AUCROCs)。

结果

我们共确定了 15741 例 SAB 患者,其中 658 例(4.18%)患有 SA-IE。AUCROC 为 0.74(95%CI 0.70-0.76),阴性预测值为 0.980(95%CI 0.977-0.983)。四个最具区分力的特征是年龄、感染性心内膜炎史、心脏瓣膜病和社区发病。

结论

我们开发了一种新的风险评分,其性能与现有评分相当,可在 SAB 发生时以及在主观临床判断之前使用。

相似文献

1
A Machine Learning-Based Risk Score for Prediction of Infective Endocarditis Among Patients With Staphylococcus aureus Bacteremia-The SABIER Score.基于机器学习的金黄色葡萄球菌菌血症患者感染性心内膜炎预测风险评分——SABIER 评分。
J Infect Dis. 2024 Sep 23;230(3):606-613. doi: 10.1093/infdis/jiae080.
2
Clinical Risk Factors for Infective Endocarditis in Bacteremia.菌血症中感染性心内膜炎的临床危险因素
Tex Heart Inst J. 2017 Feb 1;44(1):10-15. doi: 10.14503/THIJ-15-5359. eCollection 2017 Feb.
3
Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia.临床预测评分和血培养阳性时间对金黄色葡萄球菌菌血症感染性心内膜炎风险分层的作用。
J Antimicrob Chemother. 2022 Jun 29;77(7):2003-2010. doi: 10.1093/jac/dkac129.
4
Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia - a retrospective cohort study on the role of bacteriuria.金黄色葡萄球菌菌血症患者发生感染性心内膜炎和复杂感染的风险 - 关于菌尿作用的回顾性队列研究。
Eur J Clin Microbiol Infect Dis. 2024 Jul;43(7):1419-1426. doi: 10.1007/s10096-024-04850-7. Epub 2024 May 21.
5
Onset of symptoms, diagnostic confirmation, and occurrence of multiple infective foci in patients with Staphylococcus aureus bloodstream infection: a look into the order of events and potential clinical implications.金黄色葡萄球菌血流感染患者症状发作、诊断确认和多个感染灶出现的顺序:观察事件顺序和潜在临床意义。
Infection. 2018 Oct;46(5):651-658. doi: 10.1007/s15010-018-1165-x. Epub 2018 Jun 14.
6
The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia.VIRSTA 评分:一种预测金黄色葡萄球菌菌血症患者感染性心内膜炎风险和确定超声心动图检查优先级的评分。
J Infect. 2016 May;72(5):544-53. doi: 10.1016/j.jinf.2016.02.003. Epub 2016 Feb 22.
7
Time to blood culture positivity in Staphylococcus aureus bacteraemia to determine risk of infective endocarditis.金黄色葡萄球菌菌血症血培养阳性时间与感染性心内膜炎风险的关系。
Clin Microbiol Infect. 2021 Sep;27(9):1345.e7-1345.e12. doi: 10.1016/j.cmi.2020.11.007. Epub 2020 Nov 13.
8
Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia.排除金黄色葡萄球菌菌血症患者心内膜炎的预测规则。
Clin Infect Dis. 2022 Apr 28;74(8):1442-1449. doi: 10.1093/cid/ciab632.
9
Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia.使用临床工具预测心内膜炎风险(PREDICT):指导超声心动图在金黄色葡萄球菌菌血症管理中应用的评分系统
Clin Infect Dis. 2015 Jul 1;61(1):18-28. doi: 10.1093/cid/civ235. Epub 2015 Mar 25.
10
Staphylococcus aureus bacteremia and endocarditis.金黄色葡萄球菌菌血症和心内膜炎。
Cardiol Clin. 2003 May;21(2):219-33, vii. doi: 10.1016/s0733-8651(03)00030-4.

引用本文的文献

1
Evaluating Blood Culture Parameters to Identify Patients at Low Risk of Infective Endocarditis Among Those With Bacteremia by Gram-positive Cocci.评估血培养参数以识别革兰氏阳性球菌菌血症患者中感染性心内膜炎低风险患者。
Open Forum Infect Dis. 2025 Aug 22;12(9):ofaf518. doi: 10.1093/ofid/ofaf518. eCollection 2025 Sep.
2
The MEFIER Score-A Risk Score to Stratify Infective Endocarditis in Patients With Bacteremia Based on an 11-Year Territory-Wide Cohort.MEFIER评分——一种基于11年全地区队列研究对菌血症患者感染性心内膜炎进行分层的风险评分。
Open Forum Infect Dis. 2025 May 12;12(6):ofaf287. doi: 10.1093/ofid/ofaf287. eCollection 2025 Jun.
3
Change of Heart: Can Artificial Intelligence Transform Infective Endocarditis Management?
观念转变:人工智能能否改变感染性心内膜炎的治疗方式?
Pathogens. 2025 Apr 9;14(4):371. doi: 10.3390/pathogens14040371.
4
Interpreting Blood Culture Results as Early Guidance for Infective Endocarditis.解读血培养结果作为感染性心内膜炎的早期指导
JAMA Netw Open. 2025 May 1;8(5):e258079. doi: 10.1001/jamanetworkopen.2025.8079.
5
Multidisciplinary Perspectives of Challenges in Infective Endocarditis Complicated by Septic Embolic-Induced Acute Myocardial Infarction.感染性心内膜炎合并脓毒性栓塞所致急性心肌梗死挑战的多学科视角
Antibiotics (Basel). 2024 May 31;13(6):513. doi: 10.3390/antibiotics13060513.
6
Revolutionizing Cardiology through Artificial Intelligence-Big Data from Proactive Prevention to Precise Diagnostics and Cutting-Edge Treatment-A Comprehensive Review of the Past 5 Years.通过人工智能革新心脏病学——从主动预防到精准诊断与前沿治疗的大数据——过去五年的全面综述
Diagnostics (Basel). 2024 May 26;14(11):1103. doi: 10.3390/diagnostics14111103.
7
Deciphering the microbial landscape of lower respiratory tract infections: insights from metagenomics and machine learning.解析下呼吸道感染的微生物景观:宏基因组学和机器学习的新见解。
Front Cell Infect Microbiol. 2024 May 23;14:1385562. doi: 10.3389/fcimb.2024.1385562. eCollection 2024.